NO20014726D0 - Farmasöytisk sammensetning med et ekstruderingstilsetningsstoff - Google Patents
Farmasöytisk sammensetning med et ekstruderingstilsetningsstoffInfo
- Publication number
- NO20014726D0 NO20014726D0 NO20014726A NO20014726A NO20014726D0 NO 20014726 D0 NO20014726 D0 NO 20014726D0 NO 20014726 A NO20014726 A NO 20014726A NO 20014726 A NO20014726 A NO 20014726A NO 20014726 D0 NO20014726 D0 NO 20014726D0
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical composition
- extrusion additive
- extrusion
- additive
- polyalcohols
- Prior art date
Links
- 239000000654 additive Substances 0.000 title abstract 2
- 230000000996 additive effect Effects 0.000 title abstract 2
- 238000001125 extrusion Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 150000005846 sugar alcohols Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19916383A DE19916383A1 (de) | 1999-03-31 | 1999-03-31 | Pharmazeutische Zusammensetzung mit einem Extrusionsstoff |
| PCT/DE2000/001028 WO2000057853A2 (de) | 1999-03-31 | 2000-03-31 | Pharmazeutische zusammensetzung mit einem extrusionszusatzstoff |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20014726D0 true NO20014726D0 (no) | 2001-09-28 |
| NO20014726L NO20014726L (no) | 2001-11-14 |
Family
ID=7904236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20014726A NO20014726L (no) | 1999-03-31 | 2001-09-28 | Farmasöytisk sammensetning med et ekstruderingstilsetningsstoff |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1165055B1 (no) |
| JP (1) | JP2002540138A (no) |
| AT (1) | ATE306907T1 (no) |
| AU (1) | AU5058400A (no) |
| DE (2) | DE19916383A1 (no) |
| DK (1) | DK1165055T3 (no) |
| ES (1) | ES2251377T3 (no) |
| NO (1) | NO20014726L (no) |
| WO (1) | WO2000057853A2 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA200200951A1 (ru) * | 2000-03-08 | 2003-02-27 | Авд. Фарма Гмбх Унд Ко. Кг | Фармацевтические композиции |
| EP1479380B1 (en) * | 2003-05-19 | 2007-05-09 | Euro-Celtique S.A. | Use of soaps such as magnesium stearate for increasing the release of drugs |
| CN102238940B (zh) * | 2008-12-05 | 2014-07-30 | 拜耳知识产权有限责任公司 | 含针状活性物质的挤出物 |
| WO2012120365A1 (en) * | 2011-03-07 | 2012-09-13 | Aurobindo Pharma Limited | Stable pharmaceutical composition comprising ethinyl estradiol |
| GB201900389D0 (en) * | 2019-01-11 | 2019-02-27 | Queens Univ Of Belfast | Solvent and water-free lipid-based nanoparticles and their methods of manufacture |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4629621A (en) * | 1984-07-23 | 1986-12-16 | Zetachron, Inc. | Erodible matrix for sustained release bioactive composition |
| EP0406315B1 (en) * | 1988-03-24 | 1992-11-11 | Bukh Meditec A/S | Controlled release composition |
| DE69222182T2 (de) * | 1991-12-18 | 1998-02-26 | Warner Lambert Co | Verfahren für die herstellung einer festen dispersion |
| EP0744941B1 (en) * | 1994-02-16 | 2003-06-04 | Abbott Laboratories | Process for preparing fine particle pharmaceutical formulations |
| JPH0853357A (ja) * | 1994-08-08 | 1996-02-27 | Ota Seiyaku Kk | 速溶性の経口投与用アルギン酸ナトリウム固形製剤 |
| DE19504832A1 (de) * | 1995-02-14 | 1996-08-22 | Basf Ag | Feste Wirkstoff-Zubereitungen |
| DE19531277A1 (de) * | 1995-08-25 | 1997-02-27 | Basf Ag | Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren |
| DE19705538C1 (de) * | 1997-02-14 | 1998-08-27 | Goedecke Ag | Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen |
| DE19913606A1 (de) * | 1999-03-25 | 2000-09-28 | Basf Ag | Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen |
-
1999
- 1999-03-31 DE DE19916383A patent/DE19916383A1/de not_active Ceased
-
2000
- 2000-03-31 DK DK00934863T patent/DK1165055T3/da active
- 2000-03-31 AU AU50584/00A patent/AU5058400A/en not_active Abandoned
- 2000-03-31 JP JP2000607604A patent/JP2002540138A/ja active Pending
- 2000-03-31 DE DE50011380T patent/DE50011380D1/de not_active Expired - Fee Related
- 2000-03-31 EP EP00934863A patent/EP1165055B1/de not_active Expired - Lifetime
- 2000-03-31 ES ES00934863T patent/ES2251377T3/es not_active Expired - Lifetime
- 2000-03-31 WO PCT/DE2000/001028 patent/WO2000057853A2/de not_active Ceased
- 2000-03-31 AT AT00934863T patent/ATE306907T1/de not_active IP Right Cessation
-
2001
- 2001-09-28 NO NO20014726A patent/NO20014726L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1165055A2 (de) | 2002-01-02 |
| NO20014726L (no) | 2001-11-14 |
| AU5058400A (en) | 2000-10-16 |
| EP1165055B1 (de) | 2005-10-19 |
| DK1165055T3 (da) | 2006-02-27 |
| ES2251377T3 (es) | 2006-05-01 |
| ATE306907T1 (de) | 2005-11-15 |
| DE50011380D1 (de) | 2006-03-02 |
| JP2002540138A (ja) | 2002-11-26 |
| WO2000057853A2 (de) | 2000-10-05 |
| WO2000057853A3 (de) | 2001-02-22 |
| DE19916383A1 (de) | 2000-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9908578A (pt) | Composição cosmética | |
| FI972621A0 (fi) | Ei-steroidisten tulehduksenvastaisten karboksyylihappojen estereitä ja amideja, joita voidaan käyttää antioksidantteina, 5-lipoksigenaasi-inhibiittoreina ja ei-steroidisina tulehduksenvastaisina tuotteina | |
| MY127430A (en) | Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols | |
| ES2181691T3 (es) | Sistema de distribucion de droga eritropoyetina. | |
| ATE402607T1 (de) | Delta-4-desaturase-gene und ihre verwendung | |
| DK0969844T3 (da) | Indgivelse af et injicerbart antibiotikum i öret af et dyr | |
| DE69906875D1 (de) | Triglyceride und diese enthaltende Kompositionen | |
| PT1023267E (pt) | Compostos de piridilo e composicoes farmaceuticas que os contem | |
| ATE456645T1 (de) | Funktionelle acylglyceride | |
| MA26618A1 (fr) | Composes et compositions pharmaceutiques pour le traitement du paludisme | |
| DE69723395D1 (de) | Aromatische ester von polyalkylphenoxyalkanolen und treibstoffzusammensetzungen, die letztere enthalten | |
| SE9201628D0 (sv) | Pharmaceutical composition | |
| BR0007294A (pt) | Formulações farmacêuticas aperfeiçoadas | |
| CY1105318T1 (el) | Φαρμακευτικες συνθεσεις για απο του στοματος και τοπικη χορηγηση | |
| EA200200951A1 (ru) | Фармацевтические композиции | |
| DE69619979D1 (de) | Feste zusammensetzungen mit einem nicht-amorphem wirkstoff und polyäthylenoxyd | |
| DK0587087T3 (da) | Substituerede cyclohexan-derivater til behandling af sygdomme | |
| DK0912185T3 (da) | Nye farmaceutiske sammensætninger indeholdende steroidnitratesterderivater, der kan anvendes som antiinflammatoriske lægemidler | |
| KR960021018A (ko) | 약제학적 조성물 | |
| NO20014726D0 (no) | Farmasöytisk sammensetning med et ekstruderingstilsetningsstoff | |
| DE69701530D1 (de) | Zusammensetzungen in blockform mit niedrigen gehalt an fettsäure seifen | |
| SE9602617D0 (sv) | En ortoesterbaserad polymer, dess framställning och användning | |
| DE69621757D1 (de) | Mit einem aliphatischen Polycarbodiimid vernetzbare Zusammensetzungen | |
| RU94038042A (ru) | Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент | |
| AU1778200A (en) | Moulding substances based on poly-C2-6-alkylene terephthalates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |